It's too complicated to have the trial including people who do not require ventilators. The survival rate is much higher, meaning more participants needed to prove significance, and they would be wasting a lot of good cells on people who were never going to die anyway.
Save the cells for those who actually need them, and go for the conditions with the highest death rate to show as fast as possible and without a hint of doubt, that the treatment works to stop people from dying.
What's the point of dosing people who were never going to die, that's not the point of this treatment, we will not have enough cells to give to everyone, only those who are dying.
- Forums
- ASX - By Stock
- MSB
- clinicaltrials.gov - MSCs in COVID-19 ARDS
clinicaltrials.gov - MSCs in COVID-19 ARDS, page-3
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.20 |
Change
0.045(3.90%) |
Mkt cap ! $1.364B |
Open | High | Low | Value | Volume |
$1.20 | $1.21 | $1.17 | $13.35M | 11.24M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 14526 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 82506 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 48709 | 1.195 |
9 | 81507 | 1.190 |
14 | 172020 | 1.185 |
34 | 172781 | 1.180 |
8 | 115450 | 1.175 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 8806 | 12 |
1.205 | 81423 | 12 |
1.210 | 108448 | 12 |
1.215 | 178424 | 14 |
1.220 | 104320 | 12 |
Last trade - 14.51pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.20 |
  |
Change
0.045 ( 4.71 %) |
|||
Open | High | Low | Volume | ||
$1.21 | $1.21 | $1.17 | 2293586 | ||
Last updated 15.10pm 07/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online